|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1991)) |
| Is prodrug? | Yes |
| Active form | fosinoprilat |
IUPAC Name ![]() |
| (2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5833 | fosinopril |
Synonyms ![]() |
| Monopril® |
| SQ-28555 |
Database Links ![]() |
|
| CAS Registry No. | 98048-97-6 (source: PubChem) |
| ChEBI | CHEBI:5163 |
| ChEMBL Ligand | CHEMBL3039598 |
| DrugBank Ligand | DB00492 |
| PubChem CID | 9601226 |
| Search Google for chemical match using the InChIKey | BIDNLKIUORFRQP-XYGFDPSESA-N |
| Search Google for chemicals with the same backbone | BIDNLKIUORFRQP |
| Search PubMed clinical trials | fosinopril |
| Search PubMed titles | fosinopril |
| Search PubMed titles/abstracts | fosinopril |
| Wikipedia | Fosinopril |
| Comments |
| Fosinopril is a prodrug which is metabolised to the active drug fosinoprilat. Fosinopril belongs to the angiotensin-converting enzyme (ACE) inhibitor drug family. There is some ambiguity in the literature and on other resources as to the exact stereochemistry of fosinopril. The structure shown here matches that specified by the INN document. |